Cargando…

Correction to: The Economic Burden of Insulin Injection-Induced Lipohypertrophy. Role of Education: The ISTERP-3 Study

Detalles Bibliográficos
Autores principales:	Gentile, Sandro, Guarino, Giuseppina, Della Corte, Teresa, Marino, Giampiero, Satta, Ersilia, Pasquarella, Maria, Romano, Carmine, Alfrone, Carmelo, Giordano, Laura, Loiacono, Fabrizio, Capece, Maurizio, Lamberti, Rossella, Strollo, Felice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122853/ https://www.ncbi.nlm.nih.gov/pubmed/35482252 http://dx.doi.org/10.1007/s12325-022-02147-9

Ejemplares similares

The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study
por: Gentile, Sandro, et al.
Publicado: (2022)

The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study
por: Gentile, Sandro, et al.
Publicado: (2021)

Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?
por: Gentile, Sandro, et al.
Publicado: (2022)

Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case–Control Study
por: Gentile, Sandro, et al.
Publicado: (2021)

Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
por: Gentile, Sandro, et al.
Publicado: (2019)

Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey
por: Gentile, Sandro, et al.
Publicado: (2021)

Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
por: Gentile, Sandro, et al.
Publicado: (2020)

Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy
por: Gentile, Sandro, et al.
Publicado: (2020)

Effect of Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD
por: Guarino, Giuseppina, et al.
Publicado: (2023)

Insulin lipodystrophy and lipohypertrophy
por: Mokta, Jatinder K., et al.
Publicado: (2013)

A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
por: Monda, Vincenzo Maria, et al.
Publicado: (2021)

Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
por: Monda, Vincenzo Maria, et al.
Publicado: (2022)

Lipohypertrophy: prevalence, clinical consequence, and pathogenesis
por: Xu, Xiao-Han, et al.
Publicado: (2021)

Kidney and lung in pathology: mechanisms and clinical implications
por: Satta, Ersilia, et al.
Publicado: (2022)

A Systematic Survey of Physicians' Insights Into Lipohypertrophy
por: Shen, Min, et al.
Publicado: (2021)

Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma?
por: Barola, Anjana, et al.
Publicado: (2018)

Severe Abdominal Lipohypertrophy Due to Poor Insulin Management
por: Lee, Sang Ho, et al.
Publicado: (2022)

Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors
por: Omar, Magdy A, et al.
Publicado: (2011)

Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors
por: Sürücü, Hamdiye Arda, et al.
Publicado: (2018)

Prevalence of Lipohypertrophy and its Associations in Insulin-Treated Diabetic Patients
por: Nawaz, Arsalan, et al.
Publicado: (2023)

1984. Effects of Semaglutide on Adipose Tissue in HIV-Associated Lipohypertrophy
por: McComsey, Grace A, et al.
Publicado: (2023)

Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy
por: Monda, Vincenzo M., et al.
Publicado: (2023)

Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
por: Strollo, Felice, et al.
Publicado: (2017)

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
por: DeSalvo, Daniel J., et al.
Publicado: (2015)

A Child with Local Lipohypertrophy following Recombinant Human Growth Hormone Administration
por: Koppen, Ilan J. N., et al.
Publicado: (2016)

Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland
por: Innes, Steve, et al.
Publicado: (2018)

A Systematic Review of Ultrasound-Detected Lipohypertrophy in Insulin-Exposed People with Diabetes
por: Abu Ghazaleh, Haya, et al.
Publicado: (2018)

Extent of lipohypertrophy in diabetic patients—Sometimes much more than meets the eye
por: Harsch, Igor Alexander
Publicado: (2019)

Prevalence of lipohypertrophy in insulin‐treated diabetes patients: A systematic review and meta‐analysis
por: Deng, Nan, et al.
Publicado: (2017)

Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes
por: Deeb, Asma, et al.
Publicado: (2019)

Detection sensitivity of ultrasound scanning vs. clinical examination for insulin injection-related lipohypertrophy
por: Yu, Jian, et al.
Publicado: (2022)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

Machine Learning Decision Support for Detecting Lipohypertrophy With Bedside Ultrasound: Proof-of-Concept Study
por: Bandari, Ela, et al.
Publicado: (2022)

Gender Differences in Prevalence and Clinical Correlates of Lipohypertrophy in Insulin-Exposed Patients with Diabetes Mellitus
por: Peng, Siping, et al.
Publicado: (2022)

Clinical and radiological evidence of the recurrence of reversible pegvisomant-related lipohypertrophy at the new site of injection in two women with acromegaly: a case series
por: Rochira, Vincenzo, et al.
Publicado: (2012)

Recent Progress in Space Physiology and Aging
por: Strollo, Felice, et al.
Publicado: (2018)

Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)

Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
por: Gentile, Sandro, et al.
Publicado: (2016)

COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
por: Gentile, Sandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5l0pdh7cjgtcnno18p3nklhrk